Avantor Investor Conference Presentation Deck

Reconciliations of GAAP to non-GAAP measures ($M) Net cash provided by operating activities (GAAP) Capital expenditures Free cash flow (non-GAAP) Net cash (used in) investing activities (GAAP) Net cash (used in) financing activities (GAAP) Navantor™ Q4 87.0 (12.1) 74.9 (11.4) (67.4) 2019 FY 354.0 (51.6) 302.4 (42.1) (307.8) 2020 Estimates Preliminary Q4 Minimum 290.0 (20.0) 270.0 (20.0) (380.0) Preliminary FY Minimum 913.8 (61.4) 852.4 (60.3) (782.5) 39th Annual J.P. Morgan Healthcare Conference 23

View entire presentation